Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in Thailand

Trial Profile

Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in Thailand

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Feb 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 05 Feb 2022 Results published in the Vaccine
  • 01 Sep 2020 Results published in the Vaccine
  • 12 Apr 2020 Results (n=226; infants at 7months of age maternally acquired immunity against measles, mumps, rubella becomes undetectable) of children after two dose vaccination at 9 months and 2.5 years whose mothers previously received tetanus-diphtheria-acellular pertussis vaccine at 27-36 weeks of gestation were published in the Vaccine

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top